Phenotypic ex vivo drug screening
With phenotypic imaging cytometry powered ex vivo drug screening it is possible to interrogate drug responses at multiple levels going down from system level responses (cancer vs immune) to lineage (cell population) to single cell resolution to cellular processes in comprehensive integrated ways.
“Whether you are seeking to gain insights on drug efficacy in cancer cells, the cancer associated stromal cells or the cells of the immune system, understand mechanism of action or accelerate therapeutic development, by identifying exceptional responders, our ex vivo drug screening pipeline can help you reach your goal.”